Guangrong Zheng

Development of first-in-class AAK1 PROTACs for ovarian cancer

Targeting mucin-type O-glycosylation for EGFR mutant non-small cell lung cancer

Development of Caspase Cleavage Targeting Chimeras (CACTACs) for Targeted Protein Cleavage

The Florida Summer Training in Research and Oncology for the Next Generation of Researchers (STRONGER) Program

Proteolysis targeting chimera against nuclear receptor NR4A1 for melanoma therapy

Development of Caspase Cleavage Targeting Chimeras (CACTACs) for Targeted Protein Cleavage

Proteolysis targeting chimera against nuclear receptor NR4A1 for melanoma therapy

Exploring novel therapeutic strategies for combinatory therapy to treat renal clear cell carcinomas

The Role of Immune Microenvironment in Small Cell Lung Cancer

Development of first-in-class HDAC3-selective degraders for breast cancer therapy

Proteolysis-targeting chimera against BCL-XL inhibits breast cancer metastasis

Selecting a Drug Development Candidate for Cancer Treatment

Developing a Novel PROTAC-Based NR4A1 Degrader for Breast Cancer Therapy

Developing a Novel PROTAC-Based NR4A1 Degrader for Breast Cancer Therapy

Sanofi 2020 iAwards

Intercollaborative Radiation Countermeasure (INTERACT) Consortium for Advanced Development of Medical Countermeasures to Mitigate/Treat Acute and Delayed Radiation Syndromes

Identifying Novel Senolytic Agents and Molecular Targets

Inhibition of Bcl-xL by Targeted Degradation

Use of BCL-xL Proteolysis targeting chimeras to treat pancreatic cancer

Develop BCL-xL proteolysis targeting chimeras as safer and better senolytics

NCI Clinical and Translational Exploratory/ Developmental Studies

Role of Senescent Cells in Radiation-induced Pulmonary Fibrosis

Discovery and Target Identification of Senolytic Agents